Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients

about

Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome

P2860

Q26801281-AB15C645-37E4-44F1-9104-FCE98276D16B

P2860

Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients

Item

http://www.wikidata.org/entity/Q37257697

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of blocking of angiote ...... me in type 2 diabetic patients

@en

Effects of blocking of angiote ...... e in type 2 diabetic patients.

@nl

type

Item

label

Effects of blocking of angiote ...... me in type 2 diabetic patients

@en

Effects of blocking of angiote ...... e in type 2 diabetic patients.

@nl

prefLabel

Effects of blocking of angiote ...... me in type 2 diabetic patients

@en

Effects of blocking of angiote ...... e in type 2 diabetic patients.

@nl

P1476

Effects of blocking of angiote ...... me in type 2 diabetic patients

@en

P2093

Isam Hamo Mahmood

http://www.w3.org/2001/XMLSchema#string

Marwan Mohammed Merkhan

http://www.w3.org/2001/XMLSchema#string

Mohammed Najim Abed

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Metabolic syndrome: a multiplex cardiovascular risk factor

Metabolic syndrome: from epidemiology to systems biology.

Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy.

The renin angiotensin system and the metabolic syndrome

Physiology and pathophysiology of the adipose tissue renin-angiotensin system.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

P304

140-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12669/PJMS.291.2782

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259388324

http://www.w3.org/2001/XMLSchema#string

P698

24353526

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3809179

http://www.w3.org/2001/XMLSchema#string

Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients

about

P2860

P2860

Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932